Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New therapy targets shame to save teen lives

NCT ID NCT07294001

Symptom relief Sponsor: Peking University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a new type of talk therapy called Shame-Focused Cognitive Behavioral Therapy (SF-CBT) for teens hospitalized after a suicide attempt or with severe suicidal thoughts. The therapy aims to reduce feelings of shame, which are linked to suicide risk. About 42 teens aged 13-18 will receive either SF-CBT or standard supportive therapy, and researchers will track whether the therapy is feasible and acceptable, and whether it lowers suicidal thoughts and behaviors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Shame-Focused Cognitive Behavioral Therapy (SF-CBT)
What this could lead to
If it works, this could point toward a new therapy that reduces suicide risk in teens by directly targeting shame.
What could go wrong
This is a very small pilot study (42 teens) testing feasibility, not effectiveness. The therapy may not reduce suicide risk more than standard support.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 42 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

13 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adolescents aged 13-18 years, male or female. * Recent suicide risk, defined as: At least one suicide attempt in the past month, or Current suicidal ideation within the past month (with or without plan/intent) and at least one previous attempt. * Elevated shame level (baseline score ≥ 9 on the External and Internal Shame Scale, EISS). * Adequate cognitive capacity to participate in interviews and assessments. * Parent/legal guardian (or designated responsible adult authorized by guardian) provides informed consent and agrees to participate. Exclusion Criteria: * Current manic episode. * History of schizophrenia spectrum disorder, intellectual disability, or organic brain disease. * Severe psychiatric or medical conditions that impair capacity for consent or participation. * Expected to receive electroconvulsive therapy (ECT) during hospitalization. * Anticipated inpatient stay shorter than 14 days (to ensure intervention completion).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescent suicide are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicidal Ideation Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescent suicide SHAME Suicidal behavior Suicidal ideation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Peking University Sixth Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100871, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.